The final section of the guidelines is devoted to directions for future research and highlights novel therapies under investigation, particularly for patients with advanced thyroid cancer.
Explore This IssueJuly 2006
Dr. Cooper said that although patients with metastatic disease comprise a distinct minority of patients with thyroid cancer, new treatments for these patients are greatly needed given that no good treatment currently exists and that patients ultimately die of disease.
“Basically, there are a lot of drugs now becoming available in clinical trials for patients with advanced thyroid cancer,” he said.
©2006 The Triological Society